TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotec Pharmacon ASA
Closing information (x1000 DKK)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover | 63,918 | 54,215 | 55,047 |
Financial expenses | 614 | 0 | 526 |
Earnings before taxes | -4,488 | -10,295 | -18,765 |
Total assets | 58,778 | 50,639 | 46,668 |
Current assets | 44,374 | 41,595 | 37,804 |
Current liabilities | 13,911 | 10,511 | 12,763 |
Equity capital | 35,199 | 40,129 | 33,904 |
- share capital | 36,607 | 35,987 | 33,248 |
Employees (average) | 38 | 43 | 44 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency | 59.9% | 79.2% | 72.6% |
Turnover per employee | 1,682 | 1,261 | 1,251 |
Profit as a percentage of turnover | -7.0% | -19.0% | -34.1% |
Return on assets (ROA) | -6.6% | -20.3% | -39.1% |
Current ratio | 319.0% | 395.7% | 296.2% |
Return on equity (ROE) | -12.8% | -25.7% | -55.3% |
Change turnover | 8,769 | 44 | -4,424 |
Change turnover % | 16% | 0% | -7% |
Chg. No. of employees | -5 | -1 | -2 |
Chg. No. of employees % | -12% | -2% | -4% |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.